Search results
14 sie 2024 · Adults. For acute intestinal amebiasis (acute amebic dysentery): 750 mg orally three times daily for 5 to 10 days. For amebic liver abscess: 500 mg or 750 mg orally three times daily for 5 to 10 days. Pediatric patients: 35 to 50 mg/kg/24 hours, divided into three doses, orally for 10 days.
17 sie 2023 · 1 month or older: 7.5 mg/kg orally (or IV) every 6 hours for 10 days. Maximum dose: 500 mg/dose. IDSA and SHEA Recommendations for Children: Initial episode or first recurrence of nonsevere CDI: 7.5 mg/kg orally 3 or 4 times a day. Initial episode of severe/fulminant CDI: 10 mg/kg IV 3 times a day.
Maintenance dose: 7.5 mg/kg PO/IV (over 1 h) q6hr x 7-10 days (or 2-3 weeks if severe) Oral suspension. 7.5 mg/kg PO q8hr for 7-10 days; not exceed a 4 g/24 hr. Infections of...
1 lut 2024 · One-day treatment: 2 grams (g) or 20 milliliters (mL) given as a single dose or 1 g or 10 mL given in 2 divided doses per day. 7-day course treatment: 250 milligrams (mg) or 2.5 milliliters (mL) 3 times a day for 7 days. Children—Use and dose must be determined by your doctor.
9 paź 2023 · Adults: 7.5 mg/kg every 6 hours (this works out at approximately 500mg for a 70kg adult) orally for 7 to 10 days. Maximum dose 4g/24 hours. A longer course of treatment may be required for bone, joint, lower respiratory tract, and endocardium infections.
17 lut 2020 · Sequential regimen (alternative regimen): Oral: Amoxicillin 1 g twice daily plus a standard-dose PPI twice daily for 5 to 7 days; then follow with clarithromycin 500 mg twice daily, metronidazole 500 mg twice daily, and a standard-dose PPI twice daily for 5 to 7 days (ACG [Chey 2017]); some experts prefer the 10-day sequential regimen ...
The usual adult oral dosage is 7.5 mg/kg every 6 hours (approximately 500 mg for a 70 kg adult). A maximum of 4 g should not be exceeded during a 24-hour period. The usual duration of therapy is 7 to 10 days; however, infections of the bone and joint, lower respiratory tract, and endocardium may require longer treatment.
